# Nebulized Lidocaine And Ketamine Before Fiberoptic Bronchoscopy

> **NCT07743333** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 134 (actual)

## Conditions studied

- Fiberoptic Bronchoscopy (FOB)
- Lung Cancer (Diagnosis)
- Premedication

## Interventions

- **DRUG:** Nebulized lidocaine and ketamine
- **DRUG:** Nebulized Lidocaine
- **DRUG:** Lidocaine spray (2%)

## Key facts

- **NCT ID:** NCT07743333
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743333, "Nebulized Lidocaine And Ketamine Before Fiberoptic Bronchoscopy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*